NOF to Exhibit and Present at Discovery & Development US 2025
NOF to Exhibit and Present at Discovery & Development US 2025
Tokyo, Japan – September 5, 2025 – NOF CORPORATION is pleased to announce its participation in the upcoming Discovery and Development US 2025, which will be held at the Sheraton San Diego Resort, San Diego, CA, USA on October 2 and 3. The company is a Gold Sponsor in the event.
The Conference website:
https://oxfordglobal.com/discovery-development/events/discovery-development-us
As part of the event, NOF CORPORATION will showcase its products for the Drug Delivery System at Booth #67.
Furthermore, Syed Reza, Scientific and Sales Consultant, and Taiki Morita, Senior Scientist at Life Science Division will each deliver presentation on October 2, with further details outlined below.
1. Presentation at Formulation & Delivery Program
Title
Development of an Influenza LNP-mRNA Vaccine with Tailored Immunogenicity
Date & Time
October 2 / 11:50 a.m. – 12:10 p.m. (PDT)
Speaker
Syed Reza, Scientific and Sales Consultant at NOF CORPORATION
Presentation Synopsis
We will present advances in creating ionizable lipids with tunable immunogenic profiles and their use in creating vaccines favoring cellular or humoral responses. Finally, a case study of a mRNA vaccine against influenza shall be discussed.
2. Presentation at ADC Discovery & Development Program
Title
Development and Evaluation of Novel Cleavable Pendant Type PEG Linkers For ADCs
Date & Time
October 2 / 1:35 p.m. – 1:55 p.m. (PDT)
Speaker
Taiki Morita, Senior Scientist at Life Science Division, NOF CORPORATION
Presentation Synopsis
We developed cleavable pendant-type PEG linkers enabling DAR8-ADCs with reduced hydrophobicity.
PEG8/PEG12 linkers showed superior PK and efficacy over DAR4-ADCs. Notably, DAR8-ADC with PEG12
showed high tolerability with no weight loss in vivo.
For further information or to arrange a meeting, please refer to the following contact information.